Published in Child Adolesc Psychiatry Ment Health on August 07, 2013
Stability of Disruptive Mood Dysregulation Disorder Symptoms (Irritable-Angry Mood and Temper Outbursts) Throughout Childhood and Adolescence in a General Population Sample. J Abnorm Child Psychol (2015) 0.84
Prevalence of Psychiatric Disorders Among Turkish Children: The Effects of Impairment and Sociodemographic Correlates. Child Psychiatry Hum Dev (2016) 0.75
Validity of proposed DSM-5 ADHD impulsivity symptoms in children. Eur Child Adolesc Psychiatry (2016) 0.75
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry (1982) 7.37
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med (2006) 5.56
Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry (2000) 4.34
Oppositional defiant and conduct disorder: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry (2000) 4.07
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. Biol Psychiatry (2006) 3.59
An epidemiological study of disorders in late childhood and adolescence--I. Age- and gender-specific prevalence. J Child Psychol Psychiatry (1993) 3.54
Conduct disorder and oppositional defiant disorder in a national sample: developmental epidemiology. J Child Psychol Psychiatry (2004) 3.34
Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol (2012) 2.86
Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psychiatry (2004) 2.50
Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: Evidence for continuing cross-domain impairment. J Consult Clin Psychol (2006) 2.35
Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication. J Child Psychol Psychiatry (2007) 2.02
Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry (2010) 2.01
Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry (2007) 1.98
Quebec child mental health survey: prevalence of DSM-III-R mental health disorders. J Child Psychol Psychiatry (1999) 1.92
Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry (2002) 1.43
A study of disruptive behavior disorders in Puerto Rican youth: II. Baseline prevalence, comorbidity, and correlates in two sites. J Am Acad Child Adolesc Psychiatry (2006) 1.39
Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc Psychiatr Clin N Am (2008) 1.38
Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders. J Am Acad Child Adolesc Psychiatry (2001) 1.36
Four-year longitudinal study of conduct disorder in boys: patterns and predictors of persistence. J Abnorm Psychol (1995) 1.31
The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med (2008) 1.26
Attention-Deficit/Hyperactivity symptoms in Icelandic schoolchildren: assessment with the Attention Deficit/Hyperactivity Rating Scale-IV. Scand J Psychol (1999) 1.21
Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.18
Full syndrome and subthreshold attention-deficit/hyperactivity disorder in a Korean community sample: comorbidity and temperament findings. Eur Child Adolesc Psychiatry (2009) 1.12
Developing ADHD. J Child Psychol Psychiatry (2009) 1.11
ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry (1999) 1.10
Defining oppositional defiant disorder. J Child Psychol Psychiatry (2005) 1.08
Does the prevalence of CD and ODD vary across cultures? Soc Psychiatry Psychiatr Epidemiol (2010) 1.06
Toward establishing an empirical basis for the diagnosis of oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry (1996) 1.04
How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry (2008) 1.03
Prevalence of mental disorders among children in Valencia, Spain. Acta Psychiatr Scand (1994) 0.99
The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey. Eur Child Adolesc Psychiatry (2004) 0.97
Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies. BMC Psychiatry (2012) 0.95
Should there be separate parent and teacher-based categories of ODD? Evidence from a general population. J Child Psychol Psychiatry (2009) 0.91
Attention-deficit/hyperactivity disorder and comorbidity in Brazil: comparisons between two referred samples. Eur Child Adolesc Psychiatry (2004) 0.82
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
Child and adolescent mental health worldwide: evidence for action. Lancet (2011) 3.79
Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry (2007) 1.98
The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry (2010) 1.88
Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort. J Am Acad Child Adolesc Psychiatry (2010) 1.30
Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. J Am Acad Child Adolesc Psychiatry (2005) 1.16
Full syndrome and subthreshold attention-deficit/hyperactivity disorder in a Korean community sample: comorbidity and temperament findings. Eur Child Adolesc Psychiatry (2009) 1.12
Dimensions of oppositionality in a Brazilian community sample: testing the DSM-5 proposal and etiological links. J Am Acad Child Adolesc Psychiatry (2013) 1.12
Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. J Am Acad Child Adolesc Psychiatry (2006) 1.11
Child and adolescent mental health research across the globe. J Am Acad Child Adolesc Psychiatry (2012) 1.04
No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 0.99
The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet B Neuropsychiatr Genet (2008) 0.98
Food intake and serum levels of iron in children and adolescents with attention-deficit/hyperactivity disorder. Rev Bras Psiquiatr (2009) 0.97
Going global: epidemiology of child and adolescent psychopathology. J Am Acad Child Adolesc Psychiatry (2012) 0.94
ADHD treatment in Latin America and the Caribbean. J Am Acad Child Adolesc Psychiatry (2008) 0.94
Exposure to HIV in Brazilian adolescents: the impact of psychiatric symptomatology. Eur Child Adolesc Psychiatry (2007) 0.93
Are family variables associated with ADHD, inattentive type? A case-control study in schools. Eur Child Adolesc Psychiatry (2011) 0.92
Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry (2006) 0.91
ADHD in adults: a concept in evolution. Atten Defic Hyperact Disord (2012) 0.91
Evaluation of pattern recognition and feature extraction methods in ADHD prediction. Front Syst Neurosci (2012) 0.91
Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. Pharmacogenomics (2005) 0.90
High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results. Int J Methods Psychiatr Res (2014) 0.90
ADHD is undertreated in Brazil. Rev Bras Psiquiatr (2012) 0.90
Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions. J Neural Transm (Vienna) (2009) 0.90
An open-label trial of risperidone in children and adolescents with severe mood dysregulation. J Child Adolesc Psychopharmacol (2011) 0.89
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol (2009) 0.89
Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert Rev Neurother (2013) 0.88
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. J Clin Psychiatry (2009) 0.86
Broader autistic phenotype in parents of children with autism: Autism Spectrum Quotient-Turkish version. Psychiatry Clin Neurosci (2013) 0.85
Gene-environment interaction in externalizing problems among adolescents: evidence from the Pelotas 1993 Birth Cohort Study. J Child Psychol Psychiatry (2012) 0.85
Diffusion of efficacious interventions for children and adolescents with mental health problems. J Child Psychol Psychiatry (2008) 0.85
ADHD in a representative sample of the Brazilian population: estimated prevalence and comparative adequacy of criteria between adolescents and adults according to the item response theory. Int J Methods Psychiatr Res (2010) 0.85
Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder. Am J Pharmacogenomics (2004) 0.85
A current update on ADHD pharmacogenomics. Pharmacogenomics (2010) 0.85
Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry (2006) 0.84
Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing country. J Clin Psychopharmacol (2011) 0.84
Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2005) 0.84
Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial. J Child Adolesc Psychopharmacol (2007) 0.83
Preschool children with obsessive-compulsive disorder and fluoxetine treatment. Eur Child Adolesc Psychiatry (2012) 0.83
The role of a mineralocorticoid receptor gene functional polymorphism in the symptom dimensions of persistent ADHD. Eur Arch Psychiatry Clin Neurosci (2012) 0.83
Risperidone in the treatment of conduct disorder in preschool children without intellectual disability. Child Adolesc Psychiatry Ment Health (2011) 0.82
Do sluggish cognitive tempo symptoms predict response to methylphenidate in patients with attention-deficit/hyperactivity disorder-inattentive type? J Child Adolesc Psychopharmacol (2009) 0.82
Child and adolescent mental health in Latin America and the Caribbean: problems, progress, and policy research. Rev Panam Salud Publica (2005) 0.82
Attention-deficit/hyperactivity disorder and comorbidity in Brazil: comparisons between two referred samples. Eur Child Adolesc Psychiatry (2004) 0.82
Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT. Clin Nucl Med (2014) 0.82
Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. CNS Spectr (2007) 0.81
Interrater agreement for the schedule for affective disorders and schizophrenia epidemiological version for school-age children (K-SADS-E). Rev Bras Psiquiatr (2003) 0.81
Is there an association between perinatal complications and attention-deficit/hyperactivity disorder-inattentive type in children and adolescents? Rev Bras Psiquiatr (2012) 0.80
A package of interventions to reduce school dropout in public schools in a developing country. A feasibility study. Eur Child Adolesc Psychiatry (2006) 0.80
Pharmacogenetic approach for a better drug treatment in children. Curr Pharm Des (2010) 0.80
Revision of the ICD-10 mental disorders chapter: an opportunity to make suggestions. Rev Bras Psiquiatr (2008) 0.80
Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2008) 0.79
ADHD pharmacogenetics across the life cycle: New findings and perspectives. Am J Med Genet B Neuropsychiatr Genet (2014) 0.79
[Behavioral characteristics of the only child vs first-born and children with siblings]. Rev Bras Psiquiatr (2004) 0.79
The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents. Am J Med Genet B Neuropsychiatr Genet (2008) 0.78
Latent class analysis of reading, decoding, and writing performance using the Academic Performance Test: concurrent and discriminating validity. Neuropsychiatr Dis Treat (2013) 0.78
Is the prevalence of ADHD in Turkish elementary school children really high? Soc Psychiatry Psychiatr Epidemiol (2015) 0.78
Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis. BMJ Open (2014) 0.77
Depression and anxiety levels of the mothers of children and adolescents with left ventricular assist devices. Pediatr Transplant (2012) 0.77
Cadherin-13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2015) 0.77
Prevalence and correlates of gambling problems among a nationally representative sample of Brazilian adolescents. J Gambl Stud (2011) 0.77
The Val66Met polymorphism at the BDNF gene does not influence Wisconsin Card Sorting Test results in children and adolescents with bipolar disorder. Rev Bras Psiquiatr (2013) 0.76
The Brazilian contribution to Attention-Deficit/Hyperactivity Disorder molecular genetics in children and adolescents. Genet Mol Biol (2012) 0.76
An open-label trial of escitalopram in children and adolescents with social anxiety disorder. J Child Adolesc Psychopharmacol (2007) 0.76
Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Neurosci Lett (2011) 0.76
Effect of methylphenidate on neurocognitive test battery: an evaluation according to the diagnostic and statistical manual of mental disorders, fourth edition, subtypes. J Clin Psychopharmacol (2014) 0.75
Remission of maternal depression and children's psychopathology. JAMA (2006) 0.75
Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters? J Neural Transm (Vienna) (2009) 0.75
A cross-cultural comparison between samples of Brazilian and German children with ADHD/HD using the Child Behavior Checklist. Eur Arch Psychiatry Clin Neurosci (2007) 0.75
Corrigendum: An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder. Sci Rep (2016) 0.75
[The challenge of new RBP editors]. Rev Bras Psiquiatr (2008) 0.75
Attention-deficit/hyperactivity disorder in perspective. Eur Child Adolesc Psychiatry (2010) 0.75
ADHD diagnosis and treatment: exploring new areas of interest. Atten Defic Hyperact Disord (2011) 0.75
[Pharmacotherapy for the treatment of anxiety disorders in children and adolescents: a sistematic review]. Rev Bras Psiquiatr (2007) 0.75
Studies impacting the clinical world in the European Child and Adolescent Psychiatry. Eur Child Adolesc Psychiatry (2012) 0.75
Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine. J Clin Psychopharmacol (2014) 0.75
[Prevalence of anxiety and mood disorders and demographic characteristics of elementary school students]. Turk Psikiyatri Derg (2014) 0.75
Zuclopenthixol acetate treatment in children with bipolar disorder and severe aggression. J Clin Psychopharmacol (2011) 0.75
Adult mood disorders and childhood psychological trauma. Rev Bras Psiquiatr (2006) 0.75
No beneficial effects of adding parent training to methylphenidate treatment for ADHD + ODD/CD children: a 1-year prospective follow-up study. J Atten Disord (2012) 0.75
Provision of mental healthcare for children and adolescents: a worldwide view. Curr Opin Psychiatry (2015) 0.75